Skip to main content

Posts

Showing posts from May, 2017

Understanding the risk of drinking (or not drinking) wine: Meet micromort

Whether we are talking about driving a car, drinking wine, or any other routine activity, most of us are not very good at calculating risk. Life insurance company actuaries devote careers to these sorts of calculations, but even they will tell you it gets really muddled when assessing small risks of prematurely dying from everyday endeavors. With nutrition and lifestyle choices it’s practically impossible. That doesn’t stop us from trying though, and one approach is unit of measurement called the micromort . A micromort is a one in a million chance of dying ( mort from mortality .) If nothing else, it is useful in placing things in perspective; there’s even an app for tracking your micromorts as you consider lifestyle choices. Take scuba diving, for example:  5 micromorts. It is said that 3 glasses of wine equals eating 100 char-broiled steaks or spending an hour in a coal mine, for a micromort each. Really? That sounds bad, and frankly didn’t make sense to me when I heard the term

Of Wine, Charity and Health

Although wine has been associated with health since the dawn of civilization, the relationship was consummated in 1859 with the founding of the Hospices de Beaune annual charity wine auction. Built in 1443 as an almshouse and hospital for the poor, the Hospice was and is to this day supported by vineyard holdings. The auction serves to create a market for the wines, and has become a huge annual event in Burgundy. Following this lead, charity wine auctions are now held throughout the world, benefiting health care and a range of worthy causes. Some wineries now devote their profits directly to health care charities, and I would like to highlight a few of them here. Napa Valley winery Ehlers Estate is actually owned by a charitable trust, Fondation Leducq . The vineyard dates to the 1880’s, and produces 100% organic wines. The foundation, based in France, sponsors internationally collaborative research in cardiovascular and neurovascular disease.  Their grants have gone to more than 1